Sponsored by VMG Health | This email address is being protected from spambots. You need JavaScript enabled to view it. | (214) 369-4888

AmSurg Shares Rise in Value After $2.35B Sheridan Deal Announcement

Share on Facebook
Raymond James analyst John Ransom set AmSurg’s price target at $60 and upgraded his recommendation to “buy,” according to a Value Walk report.

The upgrade was made closely following AmSurg’s announcement of intention to acquire Sheridan Healthcare for $2.35 billion.

More Articles on Transactions and Valuation Issues:
4 Recent ASC Industry Acquisitions
Beloit Health System ASC Project Remains in Limbo
3 Recently Opened & Expanded Ambulatory Surgery Centers

© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

Dr. Bridget Sundell officially opens Northwoods Surgery Center in Minnesota

Read Now